Radiotherapy & Oncology
Volume 95, Issue 2 , Pages 153-157 , May 2010

Volumetric modulated arc therapy for delivery of hypofractionated stereotactic lung radiotherapy: A dosimetric and treatment efficiency analysis

Received 25 June 2009 ,Revised 21 December 2009 ,Accepted 27 December 2009.

References 

  1. Timmerman R, Papiez L, McGarry R, et al. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest. 2003;124:1946–1955
  2. Onishi H, Nagata H, Shirato K, et al. Stereotactic hypofractionated high-dose irradiation for stage I non-small cell lung carcinoma: clinical outcomes in 273 cases of a Japanese multi-institutional study. J Clin Oncol. 2004;22:7003;[ASCO Annual Meeting Proceedings (Post-meeting edition)]
  3. Onishi H, Kuriyama K, Komiyama T, et al. Clinical outcomes of stereotactic radiotherapy for stage I non-small cell lung cancer using a novel irradiation technique: patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner. Lung Cancer. 2004;45:45–55
  4. Uematsu M, Shioda A, Tahara K, et al. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience. Cancer. 1998;82:1062–1070
  5. Uematsu M, Shioda A, Taira J, et al. Computed tomography (CT)-guided stereotactic radiation therapy (SRT) for stage non-small cell lung cancer (NSCLC): 8-year results of 50 initial patients. Proc ASTRO 2003 Int J Radiat Oncol Biol Phys. 2003;57:S281
  6. Wulf J, Haedinger U, Oppitz U, et al. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys. 2004;60:186–196
  7. Hof H, Herfarth KK, Munter M, et al. Stereotactic single-dose radiotherapy of stage I non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys. 2003;56:335–341
  8. Lee S, Choi EK, Park HJ, et al. Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung. Lung Cancer. 2003;40:309–315
  9. Zimmerman FB, Geinitz H, Schill S, et al. Stereotactic hypofractionated radiotherapy in Stage I (T1–2 N0 M0) non-small cell lung cancer. Acta Oncol. 2006;45:796–801
  10. Xia T, Li H, Sun Q, et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable stage I/II NSCLC. Int J Radiat Oncol Biol Phys. 2006;66:117–125
  11. Lagerwaard FJ, Haasbeek CJ, Smit EF, et al. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2008;70:685–692
  12. Yu C, Li X, Ma L, et al. Clinical implementation of intensity-modulated arc therapy. Int J Radiat Oncol Biol Phys. 2002;53:453–463
  13. Otto K. Volumetric modulated arc therapy: IMRT in a single gantry arc. Med Phys. 2008;35:310–317
  14. Ramsey C, Spencer K, Alhakeem R, et al. Leaf position error during conformal dynamic arc and intensity modulated arc treatments. Med Phys. 2001;28:67–72
  15. Wiggenraad R, Petoukhova A, Versluis L, et al. Stereotactic radiotherapy of intracranial tumors: a comparison of intensity-modulated radiotherapy and dynamic conformal arc. Int J Radiat Oncol Biol Phys. 2009;74:1018–1026
  16. Cao D, Holmes T, Afghan M, et al. Comparison of plan quality provided by intensity-modulated arc therapy and helical tomotherapy. Int J Radiat Oncol Biol Phys. 2007;69:240–250
  17. Ma L, Yu C, Earl M, et al. Optimized intensity-modulated arc therapy for prostate cancer treatment. Int J Cancer. 2001;96:379–384
  18. Palma D, Vollans E, James K, et al. Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 2008;72:996–1001
  19. Duthoy W, De Gersem W, Vergote K, et al. Whole abdominopelvic radiotherapy (WAPRT) using intensity-modulated arc therapy (IMAT): first clinical experience. Int J Radiat Oncol Biol Phys. 2003;57:1019–1032
  20. Matuszak M, Sui H, Yan D, et al. Potential impact of volumetric modulated arc therapy on the planning and delivery of radiation therapy. Int J Radiat Oncol Biol Phys. 2008;72:S651
  21. Duthoy W, De Gersem W, Vergote K, et al. Clinical implementation of intensity-modulated arc therapy (IMAT) for rectal cancer. Int J Radiat Oncol Biol Phys. 2004;60:794–806
  22. Wong E, D’Souza D, Chen J, et al. Intensity-modulated arc therapy for treatment of high-risk endometrial malignancies. Int J Radiat Oncol Biol Phys. 2005;61:830–841
  23. Bedford J, Nordmark Hansen V, McNair H, et al. Treatment of lung cancer using volumetric modulated arc therapy and image guidance: a case study. Acta Oncol. 2008;47:1438–1443
  24. Blomgren H, Lax I, Goranson H, et al. Radiosurgery for tumors in the body: clinical experience using a new method. J Radiosurg. 1998;1:63–74
  25. Earl MA, et al. Inverse planning for intensity-modulated arc therapy using direct aperture optimization. Phys Med Biol. 2003;48:1075–1089
  26. Feuvret L, Noel G, Mazeron J, et al. Conformity index: a review. Int J Radiat Oncol Biol Phys. 2006;64:333–342
  27. Hall EJ. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys. 2006;65:1–7
  28. Reft CS, Runkel-Muller R, Myrianthopoulos L. In vivo and phantom measurements of the secondary photon and neutron doses for prostate patients undergoing 18 MV IMRT. Med Phys. 2006;33:3734–3742
  29. Seppala J, Lahtinen T, Kolmonen P. Major reduction of monitor units with the avoidance of leaf-sequencing step by direct aperture based IMRT optimization. Acta Oncol. 2009;48:426–430
  30. McGarry RC, Papiez L, Williams M, et al. Stereotactic body radiation therapy of early stage non-small-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys. 2005;63:1010–1015
  31. Nagata Y, Takayama K, Matsuo Y, et al. Clinical outcomes of a phase I/II study of 48Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys. 2005;63:1427–1431
  32. Bedford JL, Warrington AP. Commissioning of volumetric modulated arc therapy (VMAT). Int J Radiat Oncol Biol Phys. 2009;73:537–545
  33. Borst GR, Ishikawa M, Nijkamp J, et al. Radiation pneumonitis in patients treated for malignant pulmonary lesions with hypofractionated radiation therapy. Radiother Oncol. 2009;91:307–313
  34. Yenice KM, Lovelock DM, Hunt MA, et al. CT image-guided intensity-modulated therapy for paraspinal tumors using stereotactic immobilization. Int J Radiat Oncol Biol Phys. 2003;55:583–593
  35. Guckenberger M. Intra-fractional uncertainties in cone-beam CT based image-guided radiotherapy (IGRT) of pulmonary tumors. Radiother Oncol. 2007;83:57–64
  36. Wang Z, Nelson J, Yoo S, et al. Refinement of treatment setup and target localization accuracy using three-dimensional cone-beam computed tomography for stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys. 2009;73:571–577
  37. Grills I, Hugo G, Kestin L, et al. Image-guided radiotherapy via daily online cone-beam CT substantially reduces margin requirements for stereotactic lung radiotherapy. Int J Radiat Oncol Biol Phys. 2008;70:1045–1056
  38. Mackie TR, Balog J, Ruchala K, et al. Tomotherapy. Semin Radiat Oncol. 1999;9:108–117
  39. Welsh JS, Patel RR, Ritter MA, et al. Helical tomotherapy: an innovative technology and approach to radiation therapy. Technol Cancer Res Treat. 2002;1:311–316

PII: S0167-8140(10)00016-2

doi: 10.1016/j.radonc.2009.12.039

Radiotherapy & Oncology
Volume 95, Issue 2 , Pages 153-157 , May 2010

Article Tools

* Image Usage & Resolution